BPA
XLRN

Beacon Pointe Advisors’s Acceleron Pharma XLRN Stock Holding History

Beacon Pointe Advisors’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-11,763
Closed -$2.02M – 1025
2021
Q3 		$2.02M Buy
11,763
+5,554
+89% +$726K 0.05% 284
2021
Q2 		$779K Buy
+6,209
New +$783K 0.03% 380

Beacon Pointe Advisors's XLRN Position: Q4 2021 in Review

Beacon Pointe Advisors sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 11,763 shares — an estimated $2.02M sold.

Beacon Pointe Advisors first reported a position in XLRN in Q2 2021 and held it in 2 quarters. The position peaked at $2.02M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

  • Beacon Pointe Advisors reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
  • Beacon Pointe Advisors sold 11,763 Acceleron Pharma shares in Q4 2021, an estimated $2.02M.
  • Beacon Pointe Advisors first reported a position in Acceleron Pharma in Q2 2021 and held it in 2 quarters.
  • Beacon Pointe Advisors's Acceleron Pharma position peaked at $2.02M in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Beacon Pointe Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.